Liminatus Pharma, Inc. Class A Common Stock (LIMN) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Liminatus Pharma, Inc. Class A Common Stock (LIMN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.8M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 0.76 to the broader market. Liminatus Pharma, Inc. Led by Chris Kim, public since 2025-05-01.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for LIMN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →